It was good. Never visited a Scientific Update conference, but will get it on my priority list. Very good – like the set-up, flow and topics. Very interested in process development.
It was good. Never visited a Scientific Update conference, but will get it on my priority list. Very good – like the set-up, flow and topics. Very interested in process development.
It was good. Never visited a Scientific Update conference, but will get it on my priority list. Very good – like the set-up, flow and topics. Very interested in process development.
Last month I posted a scheme from showing Oppolzer’s synthesis of racemic Lysergic acid and asked if you could identify reagents or intermediates G, I, and H. Below are the answers! You can read more here in the full reference: W. Oppolzer et al, Helv. Chim. Acta 1981, 64, 478–481
Peptide drugs have very recently been in the limelight because of the success of the Novo Nordisk blockbuster GLP-1 agonist Semaglutide (Ozempic, Figure 1).1 GLP-1 agonists primarily stimulate glucose- dependent insulin release from pancreatic islets, underpinning its use in the treatment of diabetes. An add-on, equally important, function is the slowing of gastric emptying- reducing…
Bec's Bitesized Blog - Are you in the iPRD Industrial club? Last week, I had the pleasure of attending the Institute of Process Research and Development (iPRD) Industrial Club's autumn meeting in Leeds, a city that holds a special place in my heart, having spent several happy years there during my PhD studies. For those…
Green Magic: How 2024’s Peter J. Dunn Award Winners Transformed Sustainable Pharma with Breakthrough Chemistry Written by Dr Bec Newton, 24 October 2024 I happened to notice a post on LinkedIn about an ACS Webinar last week entitled ‘Sustainable Manufacturing – Green Chemistry Breakthroughs in Pharma’. I’m glad I did as the two talks were…
